Share

Philip Morris stock falls, FDA advisors say evidence doesn't back claim iQOS cuts disease risk

An FDA advisory committee said evidence doesn't support the tobacco company's claim that iQOS cuts the risk of tobacco-related diseases.
00:46
Thu, Jan 25 20182:13 PM EST